The Pharmacogenomics Centre supports several large scale publicly and privately funded research projects in pharmacogenomics as well as ongoing pharmacogenomic substudies for large pharma. It also works with public agencies such as the Public Health Agency of Canada.
Most recent publication:
Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib.. JC. Tardif et al. Circ Cardiovasc Genet. 2015;